Author:
Holowka Eric P.,Bhatia Sujata K.
Reference89 articles.
1. Office, C. B. (2006, October). Congress of the United States Congressional Budget Office Study.
2. Park, K. (1997). Controlled drug delivery: Challenges and strategies (p. 629). Washington, DC: American Chemical Society.
3. Singh, B. N., & Kim, K. H. (2000). Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. Journal of Controlled Release: Official Journal of the Controlled Release Society, 63(3), 235–259.
4. Patel, U. L., Chotai, N. P., & Nagda, C. D. (2012). Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation. Pharmaceutical Development and Technology, 17(1), 15–22.
5. Packhaeuser, C., Schnieders, J., Oster, C., & Kissel, T. (2004). In situ forming parenteral drug delivery systems: An overview. European Journal of Pharmaceutics and Biopharmaceutics, 58(2), 445–455.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献